CD8A and neoplasm: The purpose of P2RX7’s downregulation is not only to prevent T cell death by protecting antigen-reactive T cells, but also to favor the ionic activity of the receptor and to confer a better fitness of CD8+ T cells [19], which consequently enhances the control of tumor growth [20].